TB Notes Newsletter
No. 2, 2005
CDC’s annual EIS Conference was held April 11-15 here in
Atlanta. Our division was well represented in sessions on tuberculosis
investigations by our EIS officers Jawad Asghar, Kevin Cain, Alyssa
Finlay, Sarita Shah, and John Oeltmann, as well as by Peter Vranken,
an EIS officer assigned to the Louisiana Infectious Disease Epidemiology
Section. Congratulations to all of you on a job well done! I also
extend my thanks, on behalf of DTBE, to the local TB control and
health department staff who played principal roles in the investigations
being described. These collaborative investigations are an important
component of the training process for EIS officers, and I acknowledge
our indebtedness to these state and local public health professionals
for their support.
A small group of DTBE staff members gave presentations at the 9th
Annual International Union Against Tuberculosis and Lung Disease
(IUATLD) North American Region Meeting that was held February 23-26,
2005, in Vancouver, BC, Canada. Another contingent of laboratory
scientists from DTBE traveled to Canada April 2-7, 2005, to attend
and present posters at the Keystone Symposia on Infectious Disease.
The meeting, entitled “Tuberculosis: Integrating Host and
Pathogen Biology,” was an important conference for our colleagues
in the Mycobacteriology Laboratory Branch.
Members of DTBE were invited to participate in a number of World
TB Day events, and also marked the occasion with an in-house luncheon.
Please see the articles in this issue about World TB Day activities
in Atlanta and other cities.
The Seventh Semi-Annual Tuberculosis Epidemiologic Studies Consortium
(TBESC) meeting was held at Corporate Square in Atlanta on May 4
and 5. Participants heard committee and Task Order updates, and
split into breakout sessions for further discussions. Currently
TBESC members are involved in 17 research projects with study periods
ranging from 6 months to 5 years.
The 100th American Thoracic Society (ATS) International Conference
took place in San Diego, California, May 20-25. I participated in
a town hall meeting convened by Rep. Randy Cunningham and ATS President-elect
Peter D. Wagner, MD. This meeting brought together government representatives
from the United States and Mexico to discuss joint efforts in improving
completion of TB treatment for persons who cross the US-Mexico border.
The binational card and information exchange system relying on CureTB
and TBNet and other groups were prominently featured. Several symposia
and poster sessions provided opportunities to present research and
On Sunday, May 22, CDC hosted a TB public health poster session
that featured 30 posters from across the country. As always, this
informal poster session provided an opportunity to learn about new
and ongoing activities, as well as an opportunity to see old and
new friends and colleagues.
The TB Trials Consortium (TBTC) held its 17th semi-annual meeting
prior to the ATS conference. The TBTC meeting was dedicated to Earl
S. Hershfield, MD, of Manitoba, Canada, who will retire this year
from the TBTC and from TB program work. The meeting was an exceptional
one, for many reasons. One outstanding feature was the first presentation
of the preliminary results of Study 27, which is evaluating the
use of moxifloxacin and the effect of this promising new TB drug
on accelerating the time to culture conversion for patients with
smear-positive pulmonary TB. Moxifloxacin and other new drug compounds
continue to be studied by the TBTC and by other research groups
with the objective of making TB therapy easier for all.
The 2005 National TB Controllers Workshop is being held June 28–30
at the J.W. Marriott Lenox Hotel in Atlanta, Georgia. Our planning
committee has already sent out the invitation letter, which includes
registration and hotel information. We are strongly encouraging
use of the secure, online website for both conference and hotel
registration; this can be accessed at www.ntca-tb.org
or www.cdc.gov/nchstp/tb. Questions
should be directed to Ms. Carol Pozsik (678-503-0503) at NTCA or
Sherry Brown (404-639-8989) at CDC.
Kenneth G. Castro, MD
Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb
Please send comments/suggestions/requests
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333